| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Newton Charles W. Director | Sale | -550 | -4.16%12,665 | $10.04 | $5,522 | View SEC filing | |
| 2026-06-08 | Knowles Julius Director | Sale | -2,625 | -19.33%10,958 | $10.73 | $28,166 | View SEC filing | |
| 2026-06-08 | Farzan Nima Director | Sale | -2,625 | -21.18%9,767 | $10.73 | $28,166 | View SEC filing | |
| 2026-06-05 | Seth Alpna Director | Sale | -2,625 | -21.18%9,767 | $10.72 | $28,140 | View SEC filing | |
| 2026-05-19 | BIENAIME JEAN JACQUES Director | Purchase | +1,000 | +11.83%9,450 | $10.58 | $10,580 | View SEC filing | |
| 2026-04-17 | BIENAIME JEAN JACQUES Director | Purchase | +1,000 | +13.42%8,450 | $11.70 | $11,700 | View SEC filing | |
| 2026-03-11 | BIENAIME JEAN JACQUES Director | Purchase | +2,000 | +36.70%7,450 | $11.21 | $22,420 | View SEC filing | |
| 2026-02-20 | Cho Esther SVP, General Counsel | Sale | -4,745 | -10.66%39,755 | $16.35 | $77,581 | View SEC filing | |
| 2026-02-20 | Lerner Lorena Raquel Chief Science Officer | Sale | -3,873 | -11.07%31,127 | $16.35 | $63,324 | View SEC filing | |
| 2026-02-20 | Seehra Jasbir CHIEF EXECUTIVE OFFICER | Sale | -7,015 | -1.79%385,708 | $16.17 | $113,433 | View SEC filing | |
| 2026-02-20 | Regnante Keith CHIEF FINANCIAL OFFICER | Sale | -4,739 | -10.77%39,261 | $16.35 | $77,483 | View SEC filing | |
| 2025-10-17 | Kariv Tomer Director, 10% Owner | Sale | -4,787,331 | -100.00%0 | $17.75 | $84,975,125 | View SEC filing | |
| 2025-10-15 | ADAR1 Partners, LP 10% Owner | Sale | -5,389,264 | -100.00%0 | $17.75 | $95,659,436 | View SEC filing | |
| 2025-04-11 | ADAR1 Partners, LP 10% Owner | Purchase | +34,925 | +0.83%4,236,962 | $9.40 | $328,127 | View SEC filing | |
| 2025-01-24 | Regnante Keith CHIEF FINANCIAL OFFICER | Sale | -40,000 | -100.00%0 | $45.29 | $1,811,600 | View SEC filing | |
| 2024-08-15 | GORDON CARL L Director | Sale | -250,000 | -89.33%119,522 | $44.01 | $11,002,500 | View SEC filing | |
| 2024-08-15 | ORBIMED ADVISORS LLC Director | Sale | -250,000 | -89.33%119,522 | $44.01 | $11,002,500 | View SEC filing | |
| 2024-01-08 | Regnante Keith Chief Financial Officer | Sale | -40,000 | -100.00%0 | $45.29 | $1,811,600 | View SEC filing | |
| 2023-06-12 | Regnante Keith Chief Financial Officer | Sale | -40,000 | -100.00%0 | $46.61 | $1,864,239 | View SEC filing | |
| 2023-01-20 | Knowles Julius Director | Purchase | +1,191 | +100.00%1,191 | $20.98 | $24,987 | View SEC filing | |
| 2022-07-19 | Lachey Jennifer Chief Scientific Officer | Sale | -46,034 | -32.62%95,100 | $30.00 | $1,381,020 | View SEC filing | |
| 2022-07-15 | Lachey Jennifer Chief Scientific Officer | Sale | -1,916 | -1.97%95,100 | $30.00 | $57,480 | View SEC filing | |
| 2022-05-13 | Lachey Jennifer Chief Scientific Officer | Sale | -5,300 | -5.82%85,700 | $41.90 | $222,050 | View SEC filing | |
| 2022-04-13 | Lachey Jennifer Chief Scientific Officer | Sale | -5,300 | -5.82%85,700 | $62.77 | $332,705 | View SEC filing | |
| 2022-04-08 | Rovaldi Christopher Chief Operating Officer | Sale | -1,728 | -100.00%0 | $65.00 | $112,320 | View SEC filing |
1-25 of 72
